CXCL8 and cancer: IL-6, IL-8, MCP-1, RANTES, SDF-1, TGF-β1, and VEGF, among others, can shift BCCs to a more aggressive cancer phenotype, resulting eventually in increased metastatic occurrence [5, 93, 135].